Page 2 - Key Updates News Today

A comprehensive review of clinical data of atezolizumab plus bevacizumab for the treatment of unresectable HCC.

New York Governor Kathy Hochul recently signed off on anti-deed theft legislation, as outlined in Senate bill 2023-S.6577 with companion Assembly bill 2023-A.6656.[1] The Governor...

The crypto market remains bullish, with the total market cap rising to $1.61 trillion today, December 5. Also, Bitcoin’s market cap is fast

Uttarakhand Tunnel Collapse: Rescue operations are being carried out on a war footing since portions of the tunnel collapsed following a landslide on November 12

On Nov. 6, 2023, the Department of Health and Human Services (“HHS”) Office of Inspector General (the “OIG”) issued its General Compliance Program Guidance User’s Guide (“GCPG”), a...

In September, USCIS updated its policy on employment authorization documents (EADs) for specific categories such as refugees, asylees, those with pending applications for asylum...

Apple Wonderlust 2023: Key Updates: Apple CEO Tom Cook has introduced the new series of iPhones in their 2023 Wonderlust event, which took place in Apple Park, California

We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global contributors. In Industry Insights...

Expert panelists consider the real-world application of PARP inhibitor data in patients with metastatic castration-resistant prostate cancer.

Before sharing clinical pearls for the treatment of prostate cancer, key opinion leaders reflect on the potential use of immune checkpoint inhibitors in mCRPC.